Being gluten sensitive means your body reacts negatively to gluten, a protein found in wheat, barley, and rye, but you don’t have celiac disease or a wheat allergy. The medical term is non-celiac gluten sensitivity (NCGS), and it affects an estimated 4.3% of the general population. Unlike celiac disease, it doesn’t cause the kind of intestinal damage visible on a biopsy, and unlike a wheat allergy, it doesn’t trigger a classic allergic reaction. But the symptoms are real, disruptive, and can extend well beyond your gut.
How It Differs From Celiac Disease and Wheat Allergy
These three conditions share overlapping symptoms but work through completely different biological pathways. Celiac disease is autoimmune: gluten triggers the immune system to attack the lining of the small intestine, flattening the tiny finger-like projections (villi) that absorb nutrients. This damage shows up clearly on intestinal biopsies and blood tests for specific antibodies. Over time, celiac disease can lead to malabsorption, short stature in children, osteoporosis, and other autoimmune conditions.
Wheat allergy is a straightforward allergic reaction. Your immune system produces IgE antibodies against wheat proteins, which can cause hives, swelling, breathing difficulty, or even anaphylaxis within minutes to hours of eating wheat.
Gluten sensitivity sits in a different category. The immune response appears to be innate, meaning it’s a more general, less targeted reaction. There are no established antibodies to test for, no intestinal damage visible under a microscope, and the clinical presentation tends to be less severe than celiac disease. But the symptoms can still be significant enough to affect your daily life.
What the Symptoms Feel Like
Symptoms of gluten sensitivity can start anywhere from a few hours to a few days after eating gluten. The digestive symptoms overlap heavily with irritable bowel syndrome: bloating, abdominal pain, diarrhea, and sometimes constipation. This overlap is one reason the condition is so hard to pin down.
What surprises many people is the range of symptoms outside the gut. Fatigue, brain fog, headaches, joint pain, and mood changes like anxiety or depression are commonly reported. Some people notice numbness in their hands or feet. The combination of digestive and non-digestive symptoms is actually a hallmark of the condition. When gluten is removed from the diet, both types of symptoms typically improve, and they return when gluten is reintroduced.
Why Diagnosis Is Complicated
There is currently no blood test, biopsy, or biomarker that can definitively confirm gluten sensitivity. Diagnosis works by exclusion: first, celiac disease is ruled out through blood antibody tests and, if needed, an intestinal biopsy. Wheat allergy is ruled out through allergy testing. If both are negative but symptoms clearly respond to removing and reintroducing gluten, a diagnosis of NCGS is considered.
The gold-standard diagnostic approach, established by an international expert panel (the Salerno criteria), involves a double-blind, placebo-controlled gluten challenge. In this process, a person eats capsules or foods containing either gluten or a placebo without knowing which one they’re getting. The idea is to see whether gluten specifically triggers symptoms. In practice, though, this test is rarely done outside of research settings because it’s time-consuming and difficult to implement in a clinic.
There’s also a complicating psychological factor. When previous trials used this rigorous blinded approach, fewer than 20% of people who believed they were gluten sensitive had symptoms triggered specifically by gluten. Around 40% actually reported worse symptoms from the placebo than from gluten itself. This nocebo effect, where expecting a negative reaction produces one, doesn’t mean gluten sensitivity isn’t real. But it does suggest that some people who think they’re reacting to gluten may be reacting to something else entirely.
It Might Not Be the Gluten
One of the most important findings in recent years is that FODMAPs, a group of fermentable carbohydrates found in wheat and many other foods, may be the actual trigger for a significant number of people who believe they’re sensitive to gluten. Wheat happens to be high in both gluten and a specific FODMAP called fructan, so when someone removes wheat from their diet and feels better, it’s easy to credit gluten when fructans may deserve the blame.
A landmark trial from Monash University put this to the test. Researchers placed people with self-reported gluten sensitivity on a low-FODMAP diet for two weeks, and everyone improved. When they then challenged those same participants with gluten specifically (while keeping FODMAPs low), there were no gluten-specific effects on symptoms. A Norwegian study found similar results: when participants ate bars containing gluten, fructans, or placebo, fructans caused the worst symptoms overall, not gluten. A third trial published in the American Journal of Clinical Nutrition confirmed the pattern, finding that FODMAPs worsened gut symptoms while gluten performed no differently than placebo.
This doesn’t mean gluten sensitivity doesn’t exist. But it does mean that if you suspect you’re gluten sensitive, a low-FODMAP trial supervised by a dietitian may help clarify whether gluten is truly your trigger or whether fermentable carbohydrates are the real problem. The distinction matters because a low-FODMAP approach is more targeted and less restrictive than a fully gluten-free diet.
Who Is Most Likely Affected
A 2025 meta-analysis estimated the overall prevalence of NCGS at about 4.3% of the general population. The condition is roughly twice as common in women as in men (about 2.9% versus 1.2% in some estimates). It’s more common in adults (around 6.3%) than in children (about 2.3%). Interestingly, prevalence appears higher in middle- and low-income countries (4.1%) than in high-income countries (2.3%), though the reasons for this geographic variation aren’t well understood.
About half of people with NCGS carry the same genetic markers (HLA-DQ2 or HLA-DQ8) associated with celiac disease. In celiac patients, those markers are present in virtually all cases. The fact that only 50% of gluten-sensitive individuals carry them reinforces that these are distinct conditions with different underlying biology.
What Happens When You Remove Gluten
If gluten is genuinely your trigger, most people notice improvement within a few weeks of strict elimination. Some feel better within days. The timeline varies widely from person to person. Unlike celiac disease, where the intestinal lining needs months to years to fully heal, gluten sensitivity doesn’t involve that kind of structural damage, so recovery tends to be faster.
The practical challenge is maintaining a gluten-free diet accurately. Gluten hides in sauces, processed foods, beer, and even some medications. Reading labels becomes routine. If your symptoms don’t improve after several weeks of careful elimination, it’s worth reconsidering whether gluten is actually the problem, and whether FODMAPs, other food intolerances, or a different gastrointestinal condition could explain what you’re experiencing.
Emerging Tools for Identification
Researchers are actively searching for a reliable blood marker. The most promising candidate so far is zonulin, a protein that regulates the tight junctions between cells lining the intestine. People with gluten sensitivity tend to have elevated zonulin levels compared to those with irritable bowel syndrome. In one study, zonulin levels alone could distinguish NCGS from diarrhea-predominant IBS with 81% accuracy. When combined with symptom profiles and gender in a diagnostic algorithm, that accuracy rose to 89%. Another group found zonulin testing had about 71% sensitivity and 83% specificity for the same distinction.
Other markers under investigation include antibodies against gliadin (a component of gluten) and a protein called FABP2 that signals damage to intestinal lining cells. People with gluten sensitivity have shown elevated FABP2 levels that correlated with immune responses to gut bacteria leaking through the intestinal wall. None of these markers are validated for clinical use yet, but they point toward a future where diagnosis could be more straightforward than the current process of elimination and food challenges.